Expression of Cystatin C in Human Esophageal Cancer

Aims and background Cystatin C is a member of the cysteine protease inhibitors and its function is to decrease protease activity. A recent study showed that it was aberrantly expressed in many malignant tumors in association with tumor invasion and metastasis. We attempted to detect its expression i...

Full description

Saved in:
Bibliographic Details
Published inTumori Vol. 97; no. 2; pp. 203 - 210
Main Authors Zeng, Qinghong, Zhao, Yonggang, Yang, Yuxian, Zheng, Guiyu, Wang, Gefei, Zhang, Peng, Cui, Youhong, Su, Shaobo, Li, Kangsheng
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.03.2011
Subjects
Online AccessGet full text
ISSN0300-8916
2038-2529
DOI10.1177/030089161109700212

Cover

More Information
Summary:Aims and background Cystatin C is a member of the cysteine protease inhibitors and its function is to decrease protease activity. A recent study showed that it was aberrantly expressed in many malignant tumors in association with tumor invasion and metastasis. We attempted to detect its expression in esophageal cancer tissues and adjacent reparative normal tissues. Methods and design Samples of cancers and non-cancerous esophageal tissues were obtained as matched pairs from 30 surgery patients with esophageal cancer and paraffin embedded. The expression of cystatin C in tissues was investigated by immunohistochemistry. Fisher's exact test was used to analyze the relationship between esophageal cancer tissues and adjacent normal tissues. Furthermore, mRNA was extracted, and reverse transcriptase polymerase chain reaction was performed. Results The intensity of cystatin C immunostaining in tumor tissues was increased compared to that of adjacent normal tissues. mRNA expression of the cystatin C gene was greater in esophageal cancer than in normal tissues (P <0.05). Conclusions Our results indicate that cystatin C may play an important role in the pathogenesis and metastasis of esophageal cancer.
ISSN:0300-8916
2038-2529
DOI:10.1177/030089161109700212